Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 332 participants.
Also called NCT04349683
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 332 participants
- Registry
-
NCT04349683
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04349683. Randomized; double masking; primary purpose treatment. Start 2020-04-30 (anticipated); primary completion 2021-08-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Efficacy and Safety of Jinshuibao for Patients With Chronic Kidney Disease Due to Glomerulonephritis
- Condition
- Chronic Kidney Disease Stage 3B
- Condition
- Chronic Kidney Disease stage4
- Condition
- Glomerulonephritis
- Intervention (Drug)
- Jinshuibao
- Intervention (Drug)
- Placebo
- Lead sponsor
- Jemincare
- Collaborator
- Shanghai 6th People's Hospital
Record details
- Record id
cardio:ct-nct04349683- Content hash
692cb205975575be20d946b5ec618b679645928639b6b64202dfb42d55aabe5e